COVID-19

A Public Option for Clinical Trials? Lessons from Convalescent Plasma

The case of clinical trials for convalescent plasma during COVID-19 illustrates important lessons for realizing public sector approaches to biomedical research and development. These lessons, centering on mission, transparency, and spillover effects, …

Making science public: a review of journalists’ use of Open Science research

Science journalists are uniquely positioned to increase the societal impact of open science by contextualizing and communicating research findings in ways that highlight their relevance and implications for non-specialist audiences. Through …

Open science takes on the coronavirus pandemic

Data sharing, open-source designs for medical equipment, and hobbyists are all being harnessed to combat COVID-19.

Preliminary analysis of COVID-19 academic information patterns: a call for open science in the times of closed borders

The Pandemic of COVID-19, an infectious disease caused by SARS-CoV-2 motivated the scientific community to work together in order to gather, organize, process and distribute data on the novel biomedical hazard. Here, we analyzed how the scientific …

The reporting completeness and transparency of systematic reviews of prognostic prediction models for COVID-19 was poor: a methodological overview of systematic reviews

Objectives To conduct a methodological overview of reviews to evaluate the reporting completeness and transparency of systematic reviews (SRs) of prognostic prediction models (PPMs) for COVID-19. Study Design and Setting MEDLINE, Scopus, Cochrane …